Efficacy of Compound Honey Syrup on Pulmonary Symptoms and Body Mass Index in Cystic Fibrosis Patients: A Clinical Trial

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 128

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_INJPM-11-8_009

تاریخ نمایه سازی: 3 مهر 1402

چکیده مقاله:

Background: Patients with Cystic Fibrosis (CF) often have respiratory tract infections and bacterial colonization requiring antibiotic treatment. The use of complementary treatments such as Compound Honey Syrup (CHS) in Persian medicine is increasing in the treatment of diseases. This study aimed to assess the effects of Compound Honey Syrup (CHS) on CF-induced changes in pulmonary symptoms, and Body Mass Index (BMI) in children.Method: In a before/after clinical trial, ۴۴ children aged ≥۶ suffering from CF were included. They were referred to Mofid children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, between March ۲۰۲۰ and March ۲۰۲۱. The patients received their standard treatment, plus CHS (prescribed at ۵-۱۰ cc dose twice daily according to the weight of children (weight over ۳۰ kg ۱۰ ccs and under ۳۰ kg ۵ ccs) for ۱۲ weeks. The Cystic Fibrosis Questionnaire-Revised (CFQ-R) was used to determine the Severity of pulmonary symptoms. Moreover, BMIs were compared before and after CHS intervention.Results: CHS administration for ۱۲ weeks improved daily cough (P=۰.۰۰۰), sputum production (P=۰.۰۰۳), wheezing (P=۰.۰۰۰), difficulty breathing (P=۰.۰۰۲), and night-time cough scores (P=۰.۰۰۴) considerably in CF patients after intervention. Moreover, CHS consumption increased BMI (P=۰.۰۰۰) in these patients.Conclusion: It can be concluded that compound honey syrup can be a safe and effective complementary medicine to improve pulmonary symptoms and nutritional status of cystic fibrosis patients. In order to confirm these results, it is recommended to conduct more studies with larger sample sizes in order to evaluate the effect of CHS on pulmonary symptoms and BMI in cystic fibrosis patients.

کلیدواژه ها:

Cystic fibrosis ، ، ، ، ، Compound Honey Syrup (CHS) ، ، ، ، ، Respiratory Symptoms ، ، ، ، ، Body Mass Index (BMI)

نویسندگان

Saeed Sadr

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Shahpar Kaveh

Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Nafise Fadavi

Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Hanieh Tahermohammadi

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Seyed Ahmad Tabatabaei

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ghamartaj Khanbabaei

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Alireza Eshghi

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Matin pourghasem

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Parisa Honarpisheh

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Nikpendar

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Bierlaagh MC, Muilwijk D, Beekman JM, Ent CKvd, A new ...
  • Stoltz, D.A., D.K. Meyerholz, and M.J. Welsh, Origins of cystic ...
  • Ehre, C., C. Ridley, and D.J. Thornton, Cystic fibrosis: an ...
  • Garcia, A.M. and J. Dorsey, Nonpulmonary manifestations of cystic fibrosis, ...
  • Collins, S., Nutritional management of cystic fibrosis–an update for the ...
  • Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, ...
  • Girón Moreno RM, García-Clemente M, Diab-Cáceres L, Martínez-Vergara A, Martínez-García ...
  • Turcios, N.L., Cystic fibrosis lung disease: an overview. Respiratory care, ...
  • Ahmed, N.N. and P.R. Durie, Nonpulmonary manifestations of cystic fibrosis, ...
  • Konstan MW, Pasta DJ, Wagener JS, VanDevanter DR, Morgan WJ, ...
  • Qi Q, Li T, Li JC, Li Y, Association of ...
  • Mogayzel Jr PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis ...
  • Eakin, M.N. and K.A. Riekert, The impact of medication adherence ...
  • Tanase, A. and R. Zanni, The use of complementary and ...
  • Mark, J.D. and Y. Chung, Complementary and alternative medicine in ...
  • Sadr S, Kaveh S, Choopani R, Bayat H, Mosaddegh M, ...
  • Podlogar, J.A. and E.J. Verspohl, Antiinflammatory effects of ginger and ...
  • Hong JW, Yang GE, Bum Kim Y, Hyun Eom S, ...
  • Cohen HA, Rozen J, Kristal H, Laks Y, Berkovitch M, ...
  • AAHiA, I., Al Qanoun fe Al teb Al elmy al ...
  • Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, ...
  • Eccles, R., Mechanisms of the placebo effect of sweet cough ...
  • Muhamad R, Draman N, Aziz AA, Abdullah S, Jaeb MZM, ...
  • Townsend EA, Siviski ME, Zhang Y, Xu C, Hoonjan B, ...
  • Hosseinzadeh H, Ghenaati J, Evaluation of the antitussive effect of ...
  • Khan, A.-u., Q.J. Khan, and A.-H. Gilani, Pharmacological basis for ...
  • Hamad A, Alifah A, Permadi A, Hartanti D, Chemical constituents ...
  • Ahui MLB, Champy P, Ramadan A, Pham Van L, Araujo ...
  • Corren J, Lemay M, Lin Y, Rozga L, Randolph RK, ...
  • Ose R, Tu J, Schink A, Maxeiner J, Schuster P, ...
  • Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA, ...
  • Hosseini, A., B.M. Razavi, and H. Hosseinzadeh, Pharmacokinetic properties of ...
  • Seo JW, Cho SC, Park SJ, Lee EJ, Lee JH, ...
  • Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H; ...
  • Park SH, Jung SJ, Choi EK, Ha KC, Baek HI, ...
  • Abedimanesh N, Bathaie SZ, Abedimanesh S, Motlagh B, Separham A, ...
  • Erejuwa O, Ezeokpo B, Nwobodo N, Asika EC, Nwadike KI, ...
  • نمایش کامل مراجع